Several POCT devices for SCD have recently been developed based on different diagnostic principles including differential erythrocyte density [13], differential mobility of Hb S and Hb A through filter paper [14] and a polyclonal antibody-based capture immunoassay [15]. The gene discussed is GSTM1; the disease is Schnyder corneal dystrophy.